Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAM149B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HOOK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR210HG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MARCH6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASH1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UHMK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR194-2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HKR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMED8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC101929373 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTBD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUP188 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBAC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE6D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CA10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on